NCT07123662 2025-08-14
γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
Guangzhou Bio-gene Technology Co., Ltd
Phase EARLY_PHASE1 Not yet recruiting
Clinical Trials
4 trialsNCT05480501 2022-07-29
Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic Leukemia
Beijing Immunochina Medical Science & Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT04439721 2021-01-06
γδT
PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03910842 2019-09-06
Treatment of Children CD19+ Leukemia and Non-Hodgkin Lymphoma With CD19-TriCAR-T/SILK Cell Therapy
Timmune Biotech Inc.
Phase EARLY_PHASE1 Unknown